Abstract 166P
Background
Schwann cells (SCs) are a type of peripheral nerve system(PNS) glial cell that support the viability of myelinated and unmyelinated peripheral nerve fibers. Our previous studies identified SCs in human lung cancer specimens and demonstrated that SCs could increase the metastasis of lung cancer by activating the PI3K/AKT/GSK-3b/Snail-7wist signaling pathway and enhancing M2 macrophage polarization via CCL2 secretion. However, in the lung cancer mouse model, complete identification of airway nerves (or other cellular/subcellular objects) has not been possible due to patchy distribution and micron-scale size.
Methods
In this study, we describe a method using tissue clearing to acquire the first complete image of three-dimensional (3D) innervation in lung cancer. Mouse airways were harvested from the Metastatic tumor model of C57BI/6 mice and separated from the heart. The tissues were dehydrated, rehydrated and completely transparented. The specimens were labeled for the pan-neuronal marker PGP9.5 with a mouse antibody. All images were acquired using a confocal microscope. 3D images of fluorescently casted airways were processed to make airway masks. To quantify visceral pleural nerve distribution in mice, nerves were modeled using computer tractography and measured in different lung cancer regions.
Results
We found that nerves are widely distributed in both lung and lung tissues. The shape of peripheral nerves is similar to blood vessels, showing reticular shape along the bronchi and bronchioles. However, the distribution of peripheral nerves in the lung has not changed due to lung cancer. Interestingly and critically, the fluorescence intensity of the nerve near the side of lung cancer is much stronger, suggesting that the phenotype of peripheral nerves may change after interaction with lung cancer cells. The nerve growth in lung cancer tissue is abundant and active.
Conclusions
We first complete the image of three-dimensional (3D) innervation in lung cancer. The interaction between peripheral nerves and lung cancer may affect the phenotype of peripheral nerves and thus regulate the malignant biological course of lung cancer. PNS may play an oncogenic role in lung tumor progression and may serve as a therapeutic target for further analysis.
Legal entity responsible for the study
Shanghai Chest Hospital.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
90P - HAIC plus sintilimab and bevacizumab biosimilar as treatment for patients with advanced hepatocellular carcinoma (HCC): a phase II trial
Presenter: HAIBIN ZHANG
Session: Poster Display
91P - A real-world study of tislelizumab (Anti-PD-1) plus tyrosine kinase inhibitors for intermediate or advanced hepatocellular carcinoma
Presenter: Wei zhang
Session: Poster Display
92P - TAE-HAIC plus lenvatinib and PD-1 inhibitors versus TAE-HAIC plus atezolizumab and bevacizumab for unresectable hepatocellular carcinoma: A propensity score matching study
Presenter: hongjie Cai
Session: Poster Display
93P - The survival impact of the addition of durvalumab to cisplatin/gemcitabine in advanced biliary tract cancer: a real-world, retrospective, multicentric study.
Presenter: Margherita Rimini
Session: Poster Display
94P - First-line chemotherapy plus immunotherapy versus chemotherapy alone for advanced gallbladder carcinoma
Presenter: Qin-qin Liu
Session: Poster Display
95P - A single-arm, multicenter phase ? trial evaluating TQB2450 plus anlotinib combined with paclitaxel and cisplatin in first-line treatment of advanced esophageal squamous cell carcinoma (ESCC)
Presenter: Junsheng Wang
Session: Poster Display
97P - ICI for patients with MSS metastatic colorectal cancer
Presenter: Zayana Sangadzhieva
Session: Poster Display
Resources:
Abstract
99P - Efficacy and safety of toripalimab plus metronomic chemotherapy in HER2 negative metastatic breast cancer
Presenter: Hongnan Mo
Session: Poster Display